If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPURE.L Regulatory News (PURE)

  • There is currently no data for PURE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement

27 Jul 2010 07:00

RNS Number : 9585P
PureCircle Limited
27 July 2010
 



PureCircle Limited

("PureCircle or the Company")

 

 

MANAGEMENT STATEMENT

 

 

PureCircle (LSE:PURE), the world's largest producer and marketer of high quality stevia products, today provides a trading update for its financial year ended 30 June 2010 and announces further acceleration in its strategic developments.

 

FY 2010 Trading Update

 

The group will announce its preliminary results for the year ended 30 June 2010 ("FY 2010") on Wednesday 22 September 2010. In advance we provide today an unaudited trading update.

 

We expect to report sales for FY2010 in line with those of the year to 30 June 2009 ("FY 2009"). The FY 2009 Reb A business was based substantially on sales to just two customers. Almost 60 per cent of FY 2009 Group sales were to a trading partner, as opposed to an end user Food and Beverage customer. Although our supply contract with that trading partner ran through to 30 June 2010, no sales were made to them during the FY 2010 year. The Company's sales strategy post 2008 has been to work directly with end user Food and Beverage clients. In line with this strategy, the contract with the trading partner has been discontinued.

 

During FY 2010 our customer base expanded significantly. We now have more than 100 invoicing customers globally: this is the premium customer base in our industry. Most customers are currently conducting trials and testing launches. But those consumer products already launched are performing well and as their volume needs expand, they provide an excellent platform for strong growth in FY 2011 and future years.

 

FY 2010 profitability will be below FY 2009 levels. FY 2010 profits have been held back by our significantly increased investment in production overhead, sales and marketing compared to FY 2009 amounts coupled with the fact that the company is running under capacity. PureCircle's strategy is to build a large global business and we have invested heavily to do so. The current company infrastructure is designed to support a business with turnover of $250m or more.

 

FY 2010 has been another year of rapid progress in the strengthening and expansion of our global supply chain. Our major production capacity investments in FY 2009 have all performed well with actual production doubling in line with investment plans. The yields and steviolglycoside flexibility that our investments allow continue to lead the industry by some margin. We expect further strong gains in FY 2011.

 

Our leaf expansion and diversification strategy accelerated again in FY 2010. There is now stevia being grown for PureCircle in some 15 countries in four continents. The steviolglycoside content of the leaf is increasing as is the proportion of our leaf supply being sourced from PureCircle proprietary high quality strains.

 

The Company has a strong balance sheet and is well placed to expand as the stevia market accelerates. In November 2009 we raised new capital to support new expansion. We ended FY 2010 with gross cash of $65m in the balance sheet and are fully funded for existing expansion plans, particularly with the FY2009 investments still not fully utilised.

 

Strategy developments - major sugar joint ventures established

 

In February 2010 we announced the creation of Natural Sweet Ventures ("NSV") our joint venture with Imperial Sugar of the USA. NSV is the first company to market a combined sucrose and stevia product range. Customer response in the important NAFTA market has been strongly supportive.

 

Today we have announced the signing of a Memorandum Of Understanding (MOU) with British Sugar Group Plc for the creation of The Natural Sweetness Company ("TNSC"). TNSC will be a 50:50 Joint Venture and will be the first company to market sucrose stevia product combinations in the UK, Ireland, Spain, Portugal, Africa and China markets.

 

More details on the TNSC MOU are included in the separate RNS issued today.

 

The NSV and TNSC joint ventures provide a clear blueprint for how we see our strategy developing and we expect to be able to announce further strategic relationships in the coming months.

 

Strategy developments - major new global customer account gains

 

During FY 2010 we have won contracts with major new global account customers. In addition to our multi-year contracts with PepsiCo Inc and Merisant Inc, we have secured supply contracts with more major F&B companies and have secured important initial relationships with a number of major retailers. These contract wins demonstrate that PureCircle continues to secure the leading share of major F&B company relationships in the global stevia market.

 

A separate announcement on the new contracts will follow.

 

Strategy developments - industry marketing leadership

 

We have accelerated our industry marketing leadership during FY 2010 with the successful launch of a series of major initiatives.

 

In June 2010 we supported the launch of the Global Stevia Institute. This will provide independent industry- wide knowledge and consumer information leadership. Staffed and managed by highly respected medical and nutritional professionals and operating across all continents, the Global Stevia Institute is already seen as the leader in stevia thought leadership.

 

During FY 2010 we launched the Stevia by PureCircle industry trustmark. This provides robust consumer trust benefits and has been well received by our growing list of F&B clients. We expect to announce strong developments on this initiative in the near future.

 

Strategic developments - accelerating stevia product launches and approvals

 

During FY 2010 we widened the range of our high quality stevia product portfolio and we are accelerating the number and pace of product launches and regulatory approvals. The recent FDA GRAS no objection clearance for our new SG95 product is a good example of this. We expect more material product developments and clearances in FY 2011.

 

On the wider regulatory front, FY 2010 saw important progress in the important European markets. In September France gave clearance for Reb A to be sold as an ingredient. Then in March 2010 the European Food and Safety Authority (EFSA) recommended approval for 95% purity steviolglycosides. The EFSA recommendation is an important milestone towards full EU clearance for stevia.

 

Strategic developments - leaf research

 

During FY 2010 we accelerated our research and investment into improved stevia varieties. In April we announced a major research programme with Michigan State University which will complement the extensive leaf improvement work being undertaken in our operating units across the world.

 

We expect to be able to make announcements about further progress with our leaf strategy in the near future.

 

Auditors

 

With strong growth plans ahead and with a more complex international sphere of operations the Group has changed its auditors to PricewaterhouseCoopers from Crowe Horwath. The change is effective for the audit of the FY 2010 financial statements.

 

Outlook

 

FY 2010 has seen stevia become recognised as a core part of the global mass volume natural sweetener industry. All major F&B companies are now using stevia and most are now integrating stevia into their long term sweetener strategies along with sugar and corn.

 

With more than one hundred customers actively working on projects and with a high success rate for consumer product launches using PureCircle stevia, we expect sales to our existing customer base to grow strongly in FY 2011 and future years. In addition the full opening of the European market expected in FY 2011, the wider product portfolio that SG95 clearances allow and our strong sugar partnerships will each provide additional major sources of revenue growth.

 

We expect accelerated strategic progress in FY 2011, starting with the TNSC MOU announced separately today. In turn this provides the global F&B companies with further confidence that they can design stevia into their larger global brands.

 

We have a significant new product innovation pipeline. These coupled with a growing range of stevia regulatory clearances will keep PureCircle at the forefront of customer service and application development.

 

Going forward we expect to see more customers launching more products in more countries and accelerating the growth of the overall market. PureCircle is well placed to secure a major share of this growth. We have the balance sheet and the global infrastructure in place to support this

 

We look forward to reporting on further progress

 

 Chairman comment

 

"FY 2010 has seen a real acceleration in the execution of our long term corporate strategy. Our sugar partnerships and our excellent client relationships confirm our leadership position. 2011 and future years will see real market acceleration. PureCircle is well placed to secure share as this happens"

 

CEO comment

 

"We have put in place the strategy, the organisation, the capacity, the product portfolio and the partnerships for a major global business. The benefits of these will come through strongly as market demand accelerates"

 

 

 

 

 

Enquiries:

PureCircle Limited (www.purecircle.com)

Magomet Malsagov, CEO

+60 1 2388 8049

William Mitchell, CFO

+44 7974 005 163

RFC Corporate Finance (NOMAD)

+61 8 9480 2500

Steve Allen

Westport Communications

+44 20 7065 2690

Alan Frame

alan@westportcomms.com

Jeanette Bishop

jeanette@westportcomms.com

 

 

 

 

 

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSDDGDRLSDBGGL
Date   Source Headline
1st Jul 20205:10 pmRNSScheme of Arrangement becomes Effective
30th Jun 20206:00 pmRNSNew External Auditor Appointment
29th Jun 20205:45 pmRNSChanges in the Board Composition
26th Jun 20206:37 pmRNSCourt sanction of the Scheme
18th Jun 20205:47 pmRNSResults of Court Meeting and General Meeting
18th May 20205:45 pmRNSPublication of Scheme Document
7th May 20209:37 amRNSResults of Adjourned 2019 Annual General Meeting
7th May 20207:00 amRNSDispatch Date for Scheme Document
5th May 20202:31 pmRNSPDMR Notification
1st May 20207:00 amRNSBlock Listing Application
29th Apr 20207:00 amRNSNew Banking Facility
28th Apr 20203:22 pmRNSUpdate on Adjourned 2019 Annual General Meeting
20th Apr 20209:04 amRNSForm 8.3 - PureCircle Limited
20th Apr 20208:50 amRNSForm 8.3 - PureCircle Limited
20th Apr 20208:32 amRNSForm 8 (OPD) (PureCircle Limited)
16th Apr 20203:54 pmRNSForm 8.3 - PureCircle Limited
16th Apr 20203:08 pmRNSForm 8 (OPD) (PureCircle Limited)
16th Apr 20202:43 pmRNSForm 8.3 - PureCircle Limited
16th Apr 20202:40 pmRNSForm 8.3 - PureCircle Limited
16th Apr 20202:35 pmRNSForm 8.3 - PureCircle Limited
16th Apr 20202:30 pmRNSForm 8.3 - PureCircle Limited
15th Apr 20207:30 amRNSRestoration PureCircle Limited
9th Apr 20204:52 pmRNSNotice of Adjourned AGM and Annual Report
9th Apr 20202:07 pmRNSOffer for PureCircle Limited
9th Apr 20201:56 pmRNSUnaudited Interim Results and Trading Update
5th Mar 20207:00 amRNSCompany Update
5th Mar 20207:00 amRNSManagement Changes
19th Feb 20207:00 amRNSUpdate on lending facilities
10th Feb 20201:25 pmRNSResults of AGM and Directorate Change
4th Feb 20202:46 pmRNSCFO appointment effective
28th Jan 20203:45 pmRNSManagement Update
14th Jan 20204:42 pmRNSNotice of AGM and Company Update
3rd Jan 20202:00 pmRNSAppointment of CFO
2nd Jan 20207:00 amRNSBlock Listing Six Monthly Return
31st Dec 201912:15 pmRNSBoard Changes
27th Dec 20192:50 pmRNSManagement and Board Committee Changes
12th Dec 20192:40 pmRNSBoard and Management Changes
22nd Nov 20193:38 pmRNSResignation of a Director
20th Nov 20197:52 amRNSCorrection: Appointment of Directors
18th Nov 20193:42 pmRNSAppointment of Directors
14th Nov 20197:40 amRNSCompany Update
12th Nov 20192:52 pmRNSResignation of Director
28th Oct 20197:48 amRNSSuspension of share listing
25th Oct 20195:23 pmRNSPostponement of results and suspension of listing
23rd Oct 20194:35 pmRNSPrice Monitoring Extension
20th Sep 20194:40 pmRNSSecond Price Monitoring Extn
20th Sep 20194:35 pmRNSPrice Monitoring Extension
20th Sep 20194:15 pmRNSPostponement of Results
22nd Aug 20194:35 pmRNSPrice Monitoring Extension
16th Aug 20197:00 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.